Stay updated on Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, replacing v3.6.5; this signals a small update to the page's revision history rather than substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-09-01T19:35:42.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the page, indicating a minor update to the record's metadata. No substantive study details or results are indicated to be changed.
    Difference
    0.1%
    Check dated 2026-08-11T08:26:25.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a minor version update to the page. This change does not alter any study details or content.
    Difference
    0.1%
    Check dated 2026-07-28T05:00:51.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2 label. This change updates the page's revision history or UI without affecting core study information.
    Difference
    0.1%
    Check dated 2026-07-06T16:19:08.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A new revision number (v3.6.2) appears on the page as part of a small update, indicating lightweight maintenance with no apparent changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-29T09:54:49.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Recruitment status is updated to not recruiting, and new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, while the Intervention/Treatment label was updated and an older revision note (v3.5.5) was replaced with v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T08:34:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.